((2R,3S,4R,5R) -5- (4-Amino-2-oxopyrimidine-1 (2H) -yl) -2,6-dihydroxytetrahydrofuran-2-yl) methylfosfaat-13C9,15N3 (natrium)
Gecertificeerd

((2R,3S,4R,5R) -5- (4-Amino-2-oxopyrimidine-1 (2H) -yl) -2,6-dihydroxytetrahydrofuran-2-yl) methylfosfaat-13C9,15N3 (natrium)

Catalog #: HY-W011090S
Maat: 1 mg

Kwaliteit

ISO Gecertificeerd

Levering

24-48 uur

Prijs -1%
Login voor prijs
BTW niet inbegrepen
Gratis verzending vanaf €100

Technische Specificaties

Description

((2R,3S,4R,5R) -5- (4-Amino-2-oxopyrimidin-1 (2H) -yl) -3,4-dihydroxytetrahydrofuran-2-yl) methyl phosphate-13C9,15N3 (sodium) is the 13C and 15N labeled Sodium ((2R,3S,4R,5R) -5- (4-amino-2-oxopyrimidin-1 (2H) -yl) -3,4-dihydroxytetrahydrofuran-2-yl) methyl phosphate[1].

Product Name Alternative

CMP-13C9,15N3

UNSPSC

12352005

Target

Isotope-Labeled Compounds

Related Pathways

Others

Field of Research

Others

Solubility

10 mM in DMSO

Smiles

O=P(O[Na])(O[Na])O[13CH2][13C@@]1(O[13C@]([H])([15N]2[13CH]=[13CH][13C]([15NH2])=[15N][13C]2=O)[13C]([H])([13C@@]1(O)[H])O)[H]

Molecular Formula

13C9H12 15N3Na2O8P

Molecular Weight

379.07

References & Citations

[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53 (2) :211-216.

Shipping Conditions

Room temperature

Product MSDS

http://file.medchemexpress.com/batch_PDF/HY-W011090S/

Scientific Category

Isotope-Labeled Compounds

Clinical Information

No Development Reported

Beschrijving

((2R,3S,4R,5R) -5- (4-Amino-2-oxopyrimidin-1 (2H) -yl) -3,4-dihydroxytetrahydrofuran-2-yl) methyl phosphate-13C9,15N3 (sodium) is the 13C and 15N labeled Sodium

Specificaties

Productnaam((2R,3S,4R,5R) -5- (4-Amino-2-oxopyrimidine-1 (2H) -yl) -2,6-dihydroxytetrahydrofuran-2-yl) methylfosfaat-13C9,15N3 (natrium)
Categorie
Beschikbare grootte1 mg
CatalogusnummerHY-W011090S